# Deswell Industries Inc: financial statements, quarterly

DSWL · Nasdaq · CIK 946936 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/dswl.md) · [Financials](/companies/dswl/financials.md) · [Filings](/companies/dswl/filings.md) · [Insiders](/companies/dswl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dswl/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2015 (2015-03-31) | FY2016 (2016-03-31) | FY2017 (2017-03-31) | FY2018 (2018-03-31) | FY2019 (2019-03-31) | FY2020 (2020-03-31) | FY2021 (2021-03-31) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.3](/filings/0001174947-18-001008.md) | [12.0](/filings/0001174947-19-000884.md) | [8.1](/filings/0001174947-20-000830.md) | [15.2](/filings/0001174947-21-000701.md) | [14.4](/filings/0001174947-21-000701.md) | [22.5](/filings/0001174947-21-000701.md) | [20.2](/filings/0001174947-22-000859.md) | [13.5](/filings/0001174947-23-000928.md) | [22.2](/filings/0001174947-24-000982.md) | [15.8](/filings/0001174947-25-001096.md) | [28.1](/filings/0002077096-26-000231.md) | [23.1](/filings/0002077096-26-000231.md) |
| Current assets | $m | [58.2](/filings/0001174947-16-002940.md) | [50.7](/filings/0001174947-17-001059.md) | [56.1](/filings/0001174947-18-001008.md) | [68.9](/filings/0001174947-19-000884.md) | [70.0](/filings/0001174947-20-000830.md) | [65.4](/filings/0001174947-21-000701.md) | [78.7](/filings/0001174947-22-000859.md) | [87.8](/filings/0001174947-23-000928.md) | [81.2](/filings/0001174947-24-000982.md) | [83.3](/filings/0001174947-25-001096.md) | [96.5](/filings/0002077096-26-000231.md) | [107](/filings/0002077096-26-000231.md) |
| Total assets | $m | [96.4](/filings/0001174947-16-002940.md) | [87.6](/filings/0001174947-17-001059.md) | [91.0](/filings/0001174947-18-001008.md) | [100](/filings/0001174947-19-000884.md) | [100](/filings/0001174947-20-000830.md) | [95.4](/filings/0001174947-21-000701.md) | [108](/filings/0001174947-22-000859.md) | [115](/filings/0001174947-23-000928.md) | [110](/filings/0001174947-24-000982.md) | [111](/filings/0001174947-25-001096.md) | [120](/filings/0002077096-26-000231.md) | [130](/filings/0002077096-26-000231.md) |
| Current liabilities | $m | [12.4](/filings/0001174947-16-002940.md) | [10.8](/filings/0001174947-17-001059.md) | [14.8](/filings/0001174947-18-001008.md) | [19.1](/filings/0001174947-19-000884.md) | [16.2](/filings/0001174947-20-000830.md) | [14.3](/filings/0001174947-21-000701.md) | [21.2](/filings/0001174947-22-000859.md) | [24.0](/filings/0001174947-23-000928.md) | [20.2](/filings/0001174947-24-000982.md) | [16.4](/filings/0001174947-25-001096.md) | [17.7](/filings/0002077096-26-000231.md) | [20.4](/filings/0002077096-26-000231.md) |
| Total liabilities | $m | not reported | not reported | [13.9](/filings/0001174947-18-001008.md) | [18.3](/filings/0001174947-19-000884.md) | [15.5](/filings/0001174947-20-000830.md) | [15.1](/filings/0001174947-21-000701.md) | [22.2](/filings/0001174947-22-000859.md) | [24.6](/filings/0001174947-23-000928.md) | [20.7](/filings/0001174947-24-000982.md) | [16.9](/filings/0001174947-25-001096.md) | [18.1](/filings/0002077096-26-000231.md) | [20.6](/filings/0002077096-26-000231.md) |
| Shareholders' equity | $m | [84.1](/filings/0001174947-18-001008.md) | [76.8](/filings/0001174947-19-000884.md) | [76.2](/filings/0001174947-20-000830.md) | [81.3](/filings/0001174947-21-000701.md) | [84.0](/filings/0001174947-22-000859.md) | [80.3](/filings/0001174947-23-000928.md) | [85.7](/filings/0001174947-24-000982.md) | [90.8](/filings/0001174947-25-001096.md) | [89.6](/filings/0002077096-26-000231.md) | [94.2](/filings/0002077096-26-000231.md) | [102](/filings/0002077096-26-000231.md) | [109](/filings/0002077096-26-000231.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 15,885,239 at 2026-03-31, from the cover of the [20-F filed 2026-07-30](/filings/0002077096-26-000231.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.